Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial (STEP)
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer: the STEP Trial
Sponsor: Kaiser Permanente
Listed as NCT04679675, this NA trial focuses on Cervical Cancer and Cervical Dysplasia and remains completed. Sponsored by Kaiser Permanente, it has been updated 8 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2023 — Oct 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2023 — Sep 2023 [monthly]
Active Not Recruiting NA
▶ Show 3 earlier versions
-
Sep 2022 — Mar 2023 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Jun 2021 — Sep 2022 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Jun 2021 [monthly]
Enrolling By Invitation NA
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kaiser Permanente
- National Cancer Institute (NCI)
- University of Texas Southwestern Medical Center
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .